Seldon Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-107
Closed -$13.6K 256
2022
Q4
$13.6K Hold
107
0.01% 227
2022
Q3
$11K Hold
107
0.01% 248
2022
Q2
$11K Hold
107
0.01% 261
2022
Q1
$14K Sell
107
-3
-3% -$362 0.01% 261
2021
Q4
$14K Buy
+110
New +$14.4K 0.01% 260

Other funds holding ZBH

Seldon Capital's ZBH Position: Q1 2023 in Review

Seldon Capital sold out of Zimmer Biomet (ZBH) in Q1 2023, closing a stake of 107 shares — an estimated $13.6K sold.

Seldon Capital first reported a position in ZBH in Q4 2021 and held it in 5 quarters. The position peaked at $14K in Q1 2022. 993 funds tracked by Wall St. Rank hold ZBH as of Q1 2023.

  • Seldon Capital reported no remaining Zimmer Biomet position as of Q1 2023 after selling out during the quarter.
  • Seldon Capital sold 107 Zimmer Biomet shares in Q1 2023, an estimated $13.6K.
  • Seldon Capital first reported a position in Zimmer Biomet in Q4 2021 and held it in 5 quarters.
  • Seldon Capital's Zimmer Biomet position peaked at $14K in Q1 2022.
  • 993 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2023.

Based on Seldon Capital's 13F filing for Q1 2023, filed 12 May 2023.